Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Skeletal muscle involvement in friedreich ataxia and potential effects of recombinant human erythropoietin administration on muscle regeneration and neovascularization.

Nachbauer W, Boesch S, Reindl M, Eigentler A, Hufler K, Poewe W, Löscher W, Wanschitz J.

J Neuropathol Exp Neurol. 2012 Aug;71(8):708-15. doi: 10.1097/NEN.0b013e31825fed76.

PMID:
22805773
2.

Bioenergetics of the calf muscle in Friedreich ataxia patients measured by 31P-MRS before and after treatment with recombinant human erythropoietin.

Nachbauer W, Boesch S, Schneider R, Eigentler A, Wanschitz J, Poewe W, Schocke M.

PLoS One. 2013 Jul 29;8(7):e69229. doi: 10.1371/journal.pone.0069229. Print 2013.

3.

Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial.

Nachbauer W, Hering S, Seifert M, Steinkellner H, Sturm B, Scheiber-Mojdehkar B, Reindl M, Strasak A, Poewe W, Weiss G, Boesch S.

Cerebellum. 2011 Dec;10(4):763-9. doi: 10.1007/s12311-011-0287-9.

PMID:
21597884
4.

Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia.

Nachbauer W, Wanschitz J, Steinkellner H, Eigentler A, Sturm B, Hufler K, Scheiber-Mojdehkar B, Poewe W, Reindl M, Boesch S.

Mov Disord. 2011 Aug 15;26(10):1935-8. doi: 10.1002/mds.23789. Epub 2011 Jun 20.

PMID:
21692115
5.

Erythropoietin in Friedreich ataxia.

Mariotti C, Nachbauer W, Panzeri M, Poewe W, Taroni F, Boesch S.

J Neurochem. 2013 Aug;126 Suppl 1:80-7. doi: 10.1111/jnc.12301. Review.

6.

Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells.

Shi M, Ishikawa M, Kamei N, Nakasa T, Adachi N, Deie M, Asahara T, Ochi M.

Stem Cells. 2009 Apr;27(4):949-60. doi: 10.1002/stem.4.

7.

Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.

Lodi R, Rajagopalan B, Bradley JL, Taylor DJ, Crilley JG, Hart PE, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM.

Free Radic Res. 2002 Apr;36(4):461-6. Review.

PMID:
12069111
8.

Recombinant human erythropoietin: effects on frataxin expression in vitro.

Sturm B, Stupphann D, Kaun C, Boesch S, Schranzhofer M, Wojta J, Goldenberg H, Scheiber-Mojdehkar B.

Eur J Clin Invest. 2005 Nov;35(11):711-7.

PMID:
16269021
9.

Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor.

Sturm B, Helminger M, Steinkellner H, Heidari MM, Goldenberg H, Scheiber-Mojdehkar B.

Eur J Clin Invest. 2010 Jun;40(6):561-5. doi: 10.1111/j.1365-2362.2010.02292.x. Epub 2010 Apr 28.

PMID:
20456483
10.

Skin regeneration in deep second-degree scald injuries either by infusion pumping or topical application of recombinant human erythropoietin gel.

Giri P, Ebert S, Braumann UD, Kremer M, Giri S, Machens HG, Bader A.

Drug Des Devel Ther. 2015 May 11;9:2565-79. doi: 10.2147/DDDT.S79425. eCollection 2015.

11.

Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial.

Boesch S, Sturm B, Hering S, Scheiber-Mojdehkar B, Steinkellner H, Goldenberg H, Poewe W.

Mov Disord. 2008 Oct 15;23(13):1940-4. doi: 10.1002/mds.22294.

PMID:
18759345
12.

Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.

Mariotti C, Fancellu R, Caldarazzo S, Nanetti L, Di Bella D, Plumari M, Lauria G, Cappellini MD, Duca L, Solari A, Taroni F.

Mov Disord. 2012 Mar;27(3):446-9. doi: 10.1002/mds.24066. Epub 2012 Jan 4.

PMID:
22411849
13.

Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia.

Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AH.

Hum Mol Genet. 2000 Jan 22;9(2):275-82.

PMID:
10607838
14.

Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.

Lodi R, Cooper JM, Bradley JL, Manners D, Styles P, Taylor DJ, Schapira AH.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11492-5.

15.

The significance of intercalated discs in the pathogenesis of Friedreich cardiomyopathy.

Koeppen AH, Becker AB, Feustel PJ, Gelman BB, Mazurkiewicz JE.

J Neurol Sci. 2016 Aug 15;367:171-6. doi: 10.1016/j.jns.2016.06.006. Epub 2016 Jun 4.

PMID:
27423584
16.

The dorsal root ganglion in Friedreich's ataxia.

Koeppen AH, Morral JA, Davis AN, Qian J, Petrocine SV, Knutson MD, Gibson WM, Cusack MJ, Li D.

Acta Neuropathol. 2009 Dec;118(6):763-76. doi: 10.1007/s00401-009-0589-x. Epub 2009 Aug 30.

PMID:
19727777
17.

Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model.

Kao R, Xenocostas A, Rui T, Yu P, Huang W, Rose J, Martin CM.

Crit Care. 2007;11(3):R58.

18.

Erythropoietin receptor in human skeletal muscle and the effects of acute and long-term injections with recombinant human erythropoietin on the skeletal muscle.

Lundby C, Hellsten Y, Jensen MB, Munch AS, Pilegaard H.

J Appl Physiol (1985). 2008 Apr;104(4):1154-60. doi: 10.1152/japplphysiol.01211.2007. Epub 2008 Jan 24.

19.

Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.

Hart PE, Lodi R, Rajagopalan B, Bradley JL, Crilley JG, Turner C, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM.

Arch Neurol. 2005 Apr;62(4):621-6.

PMID:
15824263
20.

In children with Friedreich ataxia, muscle and ataxia parameters are associated.

Sival DA, Pouwels ME, Van Brederode A, Maurits NM, Verschuuren-Bemelmans CC, Brunt ER, Du Marchie Sarvaas GJ, Verbeek RJ, Brouwer OF, Van Der Hoeven JH.

Dev Med Child Neurol. 2011 Jun;53(6):529-34. doi: 10.1111/j.1469-8749.2011.03931.x.

Supplemental Content

Support Center